Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs PL✓SelectedUSD · PLGSK vs PL performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs PL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+69.2%
PL return
+29.8%
Excess return
+39.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioPLExcessAlpha
1D-0.1%-7.9%+7.8%0.0%
7D-1.3%-11.5%+10.2%-1.2%
30D+2.7%-6.2%+8.9%+2.8%
3M+2.7%-48.5%+51.2%+3.2%
6M+3.3%-69.4%+72.8%+4.2%
YTD+6.5%-35.5%+42.0%+6.5%
1Y+10.7%+11.6%-0.9%+9.9%
3Y+64.4%+450.6%-386.3%+57.3%
5Y+46.7%+17.0%+29.7%+41.5%
All+69.2%+29.8%+39.4%+62.9%

Cumulative growth

Daily Returns

Daily percentage return beside PL.

Daily Out/Under-Performance

Portfolio return minus PL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × PL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded PL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling